✦ LIBER ✦

Whole-blood leukodepletion filters as a source of CD34+ progenitors potentially usable in cell therapy

✍ Scribed by Zoran Ivanovic; Pascale Duchez; Doris A. Morgan; Francis Hermitte; Xavier Lafarge; Jean Chevaleyre; Vincent Praloran; Bernard Dazey; Gérard Vezon; Jean-Michel Boiron

Book ID: 109142961
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 416 KB
Volume: 46
Category: Article
ISSN: 0372-1248
DOI: 10.1111/j.1537-2995.2005.00677.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

High-dose therapy in patients with Hodgk

High-dose therapy in patients with Hodgkin’s disease: the use of selected CD34+ cells is as safe as unmanipulated peripheral blood progenitor cells

✍ Blystad, A K; Holte, H; Kvaløy, S; Smeland, E; Delabie, J; Kvalheim, G 📂 Article 📅 2001 🏛 Nature Publishing Group 🌐 English ⚖ 144 KB

Viable CD34+/CD133+ blood progenitor cel

Viable CD34+/CD133+ blood progenitor cell dose as a predictor of haematopoietic engraftment in multiple myeloma patients undergoing autologous peripheral blood stem cell transplantation

✍ C. Hicks; R. Wong; A. Manoharan; Y. L. Kwan 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 221 KB

Early apoptosis in CD34+ cells as a pote

Early apoptosis in CD34+ cells as a potential heterogeneity in quality of cryopreserved umbilical cord blood

✍ Jae-Seung Shim; Bin Cho; Myungshin Kim; Gyeong-Sin Park; Jong-Chul Shin; Hong-Ky 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 520 KB

Preferential expression of the vasoactiv

Preferential expression of the vasoactive intestinal peptide (VIP) receptor VPAC1 in human cord blood-derived CD34+CD38− cells: possible role of VIP as a growth-promoting factor for hematopoietic stem/progenitor cells

✍ Kawakami, M; Kimura, T; Kishimoto, Y; Tatekawa, T; Baba, Y; Nishizaki, T; Matsuz 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 196 KB